GR1000147B - Μεθοδος παρασκευης νεων 5-(ω-αμμωνιο-ακυλοξυ-μεθυλενιο) τετραυδροφουρανιων και τετραυδροθειοφαινιων - Google Patents

Μεθοδος παρασκευης νεων 5-(ω-αμμωνιο-ακυλοξυ-μεθυλενιο) τετραυδροφουρανιων και τετραυδροθειοφαινιων

Info

Publication number
GR1000147B
GR1000147B GR880100342A GR880100342A GR1000147B GR 1000147 B GR1000147 B GR 1000147B GR 880100342 A GR880100342 A GR 880100342A GR 880100342 A GR880100342 A GR 880100342A GR 1000147 B GR1000147 B GR 1000147B
Authority
GR
Greece
Prior art keywords
τετραυδροφουρανιων
τετραυδροθειοφαινιων
μεθυλενιο
αμμωνιο
ακυλοξυ
Prior art date
Application number
GR880100342A
Other languages
Greek (el)
English (en)
Other versions
GR880100342A (en
Inventor
Pierre Braquet
Jean-Jacques Godfroid
Francoise Heymans
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of GR880100342A publication Critical patent/GR880100342A/el
Publication of GR1000147B publication Critical patent/GR1000147B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR880100342A 1987-05-29 1988-05-23 Μεθοδος παρασκευης νεων 5-(ω-αμμωνιο-ακυλοξυ-μεθυλενιο) τετραυδροφουρανιων και τετραυδροθειοφαινιων GR1000147B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712693A GB8712693D0 (en) 1987-05-29 1987-05-29 Tetrahydrofurans etc

Publications (2)

Publication Number Publication Date
GR880100342A GR880100342A (en) 1989-02-23
GR1000147B true GR1000147B (el) 1991-09-27

Family

ID=10618139

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100342A GR1000147B (el) 1987-05-29 1988-05-23 Μεθοδος παρασκευης νεων 5-(ω-αμμωνιο-ακυλοξυ-μεθυλενιο) τετραυδροφουρανιων και τετραυδροθειοφαινιων

Country Status (32)

Country Link
US (1) US5017588A (en])
JP (1) JPH0631228B2 (en])
KR (1) KR960005152B1 (en])
AR (1) AR243885A1 (en])
AT (1) AT395715B (en])
AU (1) AU610789B2 (en])
BE (1) BE1002146A3 (en])
CA (1) CA1317959C (en])
CH (1) CH674985A5 (en])
DE (1) DE3818106A1 (en])
DK (1) DK167532B1 (en])
ES (1) ES2009924A6 (en])
FI (1) FI89353C (en])
FR (2) FR2615854B1 (en])
GB (2) GB8712693D0 (en])
GR (1) GR1000147B (en])
HK (1) HK101790A (en])
IE (1) IE61341B1 (en])
IN (1) IN168799B (en])
IT (1) IT1219698B (en])
LU (1) LU87229A1 (en])
MA (1) MA21289A1 (en])
MY (1) MY103289A (en])
NL (1) NL192203C (en])
NO (1) NO170086C (en])
NZ (1) NZ224775A (en])
OA (1) OA08878A (en])
PT (1) PT87585B (en])
SE (1) SE466449B (en])
SG (1) SG93790G (en])
TN (1) TNSN88049A1 (en])
ZA (1) ZA883731B (en])

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
US5118708A (en) * 1989-06-23 1992-06-02 Norwich Eaton Pharmaceuticals, Inc. Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
KR100326276B1 (ko) * 1999-12-14 2002-03-08 정명식 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088880A (en) * 1964-11-18 1967-10-25 Vantorex Ltd ª‡-cycloalkyleneimino-substituted esters
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc

Also Published As

Publication number Publication date
AT395715B (de) 1993-02-25
ATA140788A (de) 1992-07-15
DK167532B1 (da) 1993-11-15
SE8801964D0 (sv) 1988-05-26
FR2615735B1 (fr) 1991-01-11
DK291088D0 (da) 1988-05-27
NO882335D0 (no) 1988-05-27
IE881599L (en) 1988-11-29
ES2009924A6 (es) 1989-10-16
OA08878A (fr) 1989-10-31
DK291088A (da) 1988-11-30
NL192203C (nl) 1997-03-04
NO170086C (no) 1992-09-09
NO170086B (no) 1992-06-01
PT87585A (pt) 1989-05-31
MY103289A (en) 1993-05-29
IT1219698B (it) 1990-05-24
FI882475L (fi) 1988-11-30
KR880013928A (ko) 1988-12-22
MA21289A1 (fr) 1988-12-31
FI89353C (fi) 1993-09-27
GB8712693D0 (en) 1987-07-01
NZ224775A (en) 1990-01-29
NL8801315A (nl) 1988-12-16
GB8812488D0 (en) 1988-06-29
CA1317959C (en) 1993-05-18
SE466449B (sv) 1992-02-17
AU1672288A (en) 1988-12-01
ZA883731B (en) 1989-02-22
NL192203B (nl) 1996-11-01
IE61341B1 (en) 1994-11-02
SG93790G (en) 1991-01-18
DE3818106A1 (de) 1988-12-15
GB2205100A (en) 1988-11-30
AR243885A1 (es) 1993-09-30
SE8801964L (sv) 1988-11-30
FI882475A0 (fi) 1988-05-26
HK101790A (en) 1990-12-14
DE3818106C2 (en]) 1993-07-01
KR960005152B1 (ko) 1996-04-22
IN168799B (en]) 1991-06-08
AU610789B2 (en) 1991-05-23
FR2615854B1 (fr) 1990-12-28
FR2615735A1 (fr) 1988-12-02
LU87229A1 (fr) 1988-12-13
CH674985A5 (en]) 1990-08-15
GR880100342A (en) 1989-02-23
FI89353B (fi) 1993-06-15
JPH0631228B2 (ja) 1994-04-27
IT8820773A0 (it) 1988-05-27
BE1002146A3 (fr) 1990-07-31
GB2205100B (en) 1990-08-15
FR2615854A1 (fr) 1988-12-02
NO882335L (no) 1988-11-30
TNSN88049A1 (fr) 1990-07-10
US5017588A (en) 1991-05-21
JPS649988A (en) 1989-01-13
PT87585B (pt) 1992-09-30

Similar Documents

Publication Publication Date Title
FI874570A0 (fi) Antibakteriska medel -ii.
FR2356651A1 (fr) Nouveaux derives d'acide penicillanique et leur utilisation therapeutique
FR2614618B1 (fr) Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire
FR2448535A1 (fr) Nouveaux derives tricycliques et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2392991A1 (fr) Nouvelles 5,11-dihydro-6h-pyrido(2,3-b) (1,4) benzodiazepin-6-ones substituees en position 11, procedes pour leur preparation et medicaments renfermant ces composes
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
FI882358A0 (fi) Cykliska antikoagulationspeptider.
FI882359A0 (fi) Cykliska antikoagulationspeptider. pi path slues6208 s880524 mlues6205 m881102
GR1000147B (el) Μεθοδος παρασκευης νεων 5-(ω-αμμωνιο-ακυλοξυ-μεθυλενιο) τετραυδροφουρανιων και τετραυδροθειοφαινιων
GR1000420B (el) Μεθοδος παρασκευης σουλφονυλικων παραγωγων των θειενο-τριαζολο-διαζεπινων.
FI903833A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoketonijohdannaisten valmistamiseksi
IT1116482B (it) Procedimento per la produzione di p-fenilendiammine n-fenil-n'-sostituite asimmetriche
PT88636A (pt) A process for the preparation of novel aminoalkyl-substituted heterocyclic sulfur compounds and of pharmaceutical compositionscontaining the same
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
IT1121456B (it) 2 4 etil i pipera inil 4 fenilchinoline procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali composti
FR2396001A1 (fr) Derives a-acetyleniques et a-vinyliques d'amino-acides utiles comme medicaments et leur procede de preparation
GR900100356A (el) Νέα παράγωγα 9α-υδροξυ-3-οξο4,24(25)-στιγμασταδιέν-26-οϊκού οξέος και μέ?οδος για την παρασκευή τους.
ES2075137T3 (es) Compuestos sustituidos de piridina; su produccion y composiciones farmaceuticas que los contienen.
FR2407214A1 (fr) Nouvelles amidino-7 b cephalosporines substituees utiles notamment comme antibiotiques et leur procede de preparation
IT8621734A0 (it) Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina
FR2370050A1 (fr) Derives quinolizidylideniques de xanthenes, thioxanthenes et dibenzoxepines, leur procede de preparation et leur application en therapeutique
GR1000883B (el) Μέ?οδος παρασκευής παραγώγων σεληνοφαινίου.
GR880100452A (el) Μυκητοκτονες συνθεσεις με βαση νικοτινικα παραγωγα,νεα νικοτινικα παραγωγα και η παρασκευη τους
GR1000138B (el) Νεα παραγωγα ριβοφουρανουρονικου οξεος, μεθοδος δια την παρασευη αυτων και η χρησιμοποιησις αυτων.
PT88578A (pt) Process for the manufacture of 2,6-methanopyrrolo-3-benzazocines of intermediates useful for their manufacture and of pharmaceutical compositions containing them

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees